Extracellular vesicles from oviductal and uterine fluids supplementation in sequential in vitro culture improves bovine embryo quality.
Cattle
Cryopreservation
Embryo development
Exosomes
Lipid metabolism
Oviduct
Uterus
miRNAs
Journal
Journal of animal science and biotechnology
ISSN: 1674-9782
Titre abrégé: J Anim Sci Biotechnol
Pays: England
ID NLM: 101581293
Informations de publication
Date de publication:
25 Oct 2022
25 Oct 2022
Historique:
received:
13
04
2022
accepted:
31
07
2022
entrez:
25
10
2022
pubmed:
26
10
2022
medline:
26
10
2022
Statut:
epublish
Résumé
In vitro production of bovine embryos is a well-established technology, but the in vitro culture (IVC) system still warrants improvements, especially regarding embryo quality. This study aimed to evaluate the effect of extracellular vesicles (EVs) isolated from oviductal (OF) and uterine fluid (UF) in sequential IVC on the development and quality of bovine embryos. Zygotes were cultured in SOF supplemented with either BSA or EVs-depleted fetal calf serum (dFCS) in the presence (BSA-EV and dFCS-EV) or absence of EVs from OF (D1 to D4) and UF (D5 to D8), mimicking in vivo conditions. EVs from oviducts (early luteal phase) and uterine horns (mid-luteal phase) from slaughtered heifers were isolated by size exclusion chromatography. Blastocyst rate was recorded on days 7-8 and their quality was assessed based on lipid contents, mitochondrial activity and total cell numbers, as well as survival rate after vitrification. Relative mRNA abundance for lipid metabolism-related transcripts and levels of phosphorylated hormone-sensitive lipase (pHSL) proteins were also determined. Additionally, the expression levels of 383 miRNA in OF- and UF-EVs were assessed by qRT-PCR. Blastocyst yield was lower (P < 0.05) in BSA treatments compared with dFCS treatments. Survival rates after vitrification/warming were improved in dFCS-EVs (P < 0.05). EVs increased (P < 0.05) blastocysts total cell number in dFCS-EV and BSA-EV compared with respective controls (dFCS and BSA), while lipid content was decreased in dFCS-EV (P < 0.05) and mitochondrial activity did not change (P > 0.05). Lipid metabolism transcripts were affected by EVs and showed interaction with type of protein source in medium (PPARGC1B, LDLR, CD36, FASN and PNPLA2, P < 0.05). Levels of pHSL were lower in dFCS (P < 0.05). Twenty miRNA were differentially expressed between OF- and UF-EVs and only bta-miR-148b was increased in OF-EVs (P < 0.05). Mimicking physiological conditions using EVs from OF and UF in sequential IVC does not affect embryo development but improves blastocyst quality regarding survival rate after vitrification/warming, total cell number, lipid content, and relative changes in expression of lipid metabolism transcripts and lipase activation. Finally, EVs miRNA contents may contribute to the observed effects.
Sections du résumé
BACKGROUND
BACKGROUND
In vitro production of bovine embryos is a well-established technology, but the in vitro culture (IVC) system still warrants improvements, especially regarding embryo quality. This study aimed to evaluate the effect of extracellular vesicles (EVs) isolated from oviductal (OF) and uterine fluid (UF) in sequential IVC on the development and quality of bovine embryos. Zygotes were cultured in SOF supplemented with either BSA or EVs-depleted fetal calf serum (dFCS) in the presence (BSA-EV and dFCS-EV) or absence of EVs from OF (D1 to D4) and UF (D5 to D8), mimicking in vivo conditions. EVs from oviducts (early luteal phase) and uterine horns (mid-luteal phase) from slaughtered heifers were isolated by size exclusion chromatography. Blastocyst rate was recorded on days 7-8 and their quality was assessed based on lipid contents, mitochondrial activity and total cell numbers, as well as survival rate after vitrification. Relative mRNA abundance for lipid metabolism-related transcripts and levels of phosphorylated hormone-sensitive lipase (pHSL) proteins were also determined. Additionally, the expression levels of 383 miRNA in OF- and UF-EVs were assessed by qRT-PCR.
RESULTS
RESULTS
Blastocyst yield was lower (P < 0.05) in BSA treatments compared with dFCS treatments. Survival rates after vitrification/warming were improved in dFCS-EVs (P < 0.05). EVs increased (P < 0.05) blastocysts total cell number in dFCS-EV and BSA-EV compared with respective controls (dFCS and BSA), while lipid content was decreased in dFCS-EV (P < 0.05) and mitochondrial activity did not change (P > 0.05). Lipid metabolism transcripts were affected by EVs and showed interaction with type of protein source in medium (PPARGC1B, LDLR, CD36, FASN and PNPLA2, P < 0.05). Levels of pHSL were lower in dFCS (P < 0.05). Twenty miRNA were differentially expressed between OF- and UF-EVs and only bta-miR-148b was increased in OF-EVs (P < 0.05).
CONCLUSIONS
CONCLUSIONS
Mimicking physiological conditions using EVs from OF and UF in sequential IVC does not affect embryo development but improves blastocyst quality regarding survival rate after vitrification/warming, total cell number, lipid content, and relative changes in expression of lipid metabolism transcripts and lipase activation. Finally, EVs miRNA contents may contribute to the observed effects.
Identifiants
pubmed: 36280872
doi: 10.1186/s40104-022-00763-7
pii: 10.1186/s40104-022-00763-7
pmc: PMC9594899
doi:
Types de publication
Journal Article
Langues
eng
Pagination
116Informations de copyright
© 2022. The Author(s).
Références
FEBS Open Bio. 2021 Mar;11(3):753-767
pubmed: 33533170
Mol Reprod Dev. 2002 Feb;61(2):234-48
pubmed: 11803560
Int J Mol Sci. 2018 Dec 21;20(1):
pubmed: 30577682
Theriogenology. 2000 Jan 1;53(1):21-34
pubmed: 10735059
Biol Reprod. 2003 Jan;68(1):236-43
pubmed: 12493719
Reproduction. 2020 May;159(5):503-511
pubmed: 32103820
J Lipid Res. 2018 Oct;59(10):1793-1804
pubmed: 29678957
Theriogenology. 2020 Dec;158:267-276
pubmed: 33002770
Braz J Med Biol Res. 2015 Mar;48(3):191-7
pubmed: 25627805
Int J Mol Sci. 2020 Jul 27;21(15):
pubmed: 32727074
PLoS One. 2014 Mar 10;9(3):e90913
pubmed: 24614226
Biol Reprod. 2000 Apr;62(4):847-56
pubmed: 10727252
Int J Mol Sci. 2020 Jul 27;21(15):
pubmed: 32727154
Int J Mol Sci. 2020 Feb 14;21(4):
pubmed: 32075098
Physiol Genomics. 2008 Jan 17;32(2):264-72
pubmed: 17986520
Int J Mol Sci. 2020 Apr 20;21(8):
pubmed: 32325999
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3394-9
pubmed: 20133684
Front Immunol. 2018 Feb 02;9:167
pubmed: 29456541
Reprod Fertil Dev. 2017 Mar;29(3):621-629
pubmed: 26462440
Int J Mol Sci. 2019 Dec 28;21(1):
pubmed: 31905654
Mol Reprod Dev. 2021 Sep;88(9):628-643
pubmed: 34402123
Reprod Nutr Dev. 1998 Nov-Dec;38(6):579-94
pubmed: 9932292
J Vis Exp. 2012 Jan 09;(59):e3037
pubmed: 22257828
Reproduction. 2020 Dec;160(6):887-903
pubmed: 33112768
Am J Physiol Endocrinol Metab. 2013 Mar 15;304(6):E599-613
pubmed: 23321473
Cell Metab. 2012 Mar 7;15(3):279-91
pubmed: 22405066
Reprod Fertil Dev. 2018 Jun;30(7):935-945
pubmed: 29167013
PLoS One. 2017 Mar 28;12(3):e0174535
pubmed: 28350875
Nature. 2010 Aug 12;466(7308):835-40
pubmed: 20703300
Theriogenology. 2018 Jul 1;114:199-205
pubmed: 29653387
Int J Mol Sci. 2016 Oct 13;17(10):
pubmed: 27754357
Mol Reprod Dev. 2002 Jul;62(3):320-7
pubmed: 12112595
Biochem Biophys Res Commun. 2018 Jan 1;495(1):1370-1375
pubmed: 29196267
Adv Drug Deliv Rev. 2020;159:308-321
pubmed: 32151658
Reprod Domest Anim. 2010 Oct;45(5):832-7
pubmed: 19416481
Reproduction. 2017 Sep;154(3):153-168
pubmed: 28630101
Mol Reprod Dev. 2007 Apr;74(4):445-54
pubmed: 16998855
Reprod Domest Anim. 2005 Feb;40(1):76-8
pubmed: 15655006
Theriogenology. 2009 Mar 1;71(4):690-7
pubmed: 18995895
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Reprod Sci. 2013 Mar;20(3):308-17
pubmed: 22902743
Int J Mol Med. 2017 Sep;40(3):834-844
pubmed: 28737826
Reproduction. 2017 Apr;153(4):461-470
pubmed: 28104825
Sci Rep. 2019 Dec 30;9(1):20330
pubmed: 31889113
Biol Reprod. 2000 Feb;62(2):463-9
pubmed: 10642588
Biol Reprod. 2017 Oct 1;97(4):644-655
pubmed: 29025042
Theriogenology. 2020 Jul 1;150:139-149
pubmed: 31973965
Methods Mol Biol. 2021;2273:219-238
pubmed: 33604857
Infect Genet Evol. 2017 Sep;53:146-154
pubmed: 28546080
Reprod Domest Anim. 2008 Oct;43 Suppl 4:44-50
pubmed: 18803756
Reprod Fertil Dev. 2015 May 19;:
pubmed: 25986410
Theriogenology. 2020 Jul 1;150:106-112
pubmed: 32164992
Biochem Biophys Res Commun. 2021 Oct 8;573:100-106
pubmed: 34403805
Trends Endocrinol Metab. 2017 Jan;28(1):3-18
pubmed: 27810172
Braz J Med Biol Res. 2014 Feb;47(3):192-205
pubmed: 24676492
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Biol Reprod. 2002 Mar;66(3):589-95
pubmed: 11870062
J Dairy Sci. 1980 Jan;63(1):155-60
pubmed: 7372895
BMC Genomics. 2018 Aug 22;19(1):622
pubmed: 30134841
Cells. 2020 Jul 02;9(7):
pubmed: 32630649
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Int J Mol Sci. 2020 Feb 10;21(3):
pubmed: 32050564
RNA Biol. 2017 Oct 3;14(10):1326-1334
pubmed: 26853707
J Anim Sci. 2019 May 30;97(6):2555-2568
pubmed: 30968113
PLoS One. 2018 Jan 23;13(1):e0191023
pubmed: 29360833
J Reprod Dev. 2008 Aug;54(4):239-43
pubmed: 18441502
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
PLoS One. 2017 Nov 8;12(11):e0187569
pubmed: 29117219
Mol Reprod Dev. 2007 Nov;74(11):1395-405
pubmed: 17342731
J Reprod Dev. 2015;61(2):138-44
pubmed: 25739861
J Mol Cell Biol. 2015 Feb;7(1):12-22
pubmed: 25635127
PLoS One. 2016 Feb 04;11(2):e0148083
pubmed: 26845570
Animal. 2020 May;14(5):991-1004
pubmed: 31760966
PLoS One. 2017 Jun 15;12(6):e0179451
pubmed: 28617821
BMC Genomics. 2016 Jan 22;17:72
pubmed: 26801242
Biol Reprod. 2016 Mar;94(3):56
pubmed: 26819476
Int J Mol Sci. 2020 Aug 01;21(15):
pubmed: 32752293
Cell Commun Signal. 2018 Apr 16;16(1):16
pubmed: 29661252
Mol Reprod Dev. 2002 Jan;61(1):57-66
pubmed: 11774376
Theriogenology. 2017 Jan 1;87:108-114
pubmed: 27634395
J Extracell Vesicles. 2018 Jan 21;7(1):1422674
pubmed: 29410778
Theriogenology. 2002 Mar 1;57(4):1273-83
pubmed: 12013447
J Endocrinol. 2018 Jan;236(1):R15-R27
pubmed: 28870888
Theriogenology. 2001 Mar 1;55(4):923-36
pubmed: 11291915
Theriogenology. 1999 Sep;52(4):683-700
pubmed: 10734366
J Extracell Vesicles. 2021 Jan;10(3):e12061
pubmed: 33532042
Theriogenology. 2011 Feb;75(3):434-44
pubmed: 21111465
Reprod Fertil Dev. 2020 Apr;32(7):667-675
pubmed: 32172783